## TSN: Tyson Foods, Inc. - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_10 -1.9% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($55.09)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 3
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Tyson Foods Announces First Quarter Earnings Conference Call and Webcast**
- Source: The Manila Times | 20260105T221126 | Neutral | Relevance: 100%
- Tyson Foods, Inc. (NYSE: TSN) will release its first-quarter 2026 financial results on Monday, February 2, 2026. Management will host a conference call and webcast at 9:00 a.m. Eastern Time (8:00 a.m. Central Time) to discuss the results. A replay of the webcast and audio will be available online and via telephone until Monday, March 2, 2026.

**2. The Truth About Pilgrim s Pride Corp: Is PPC the Sleeper Stock Everyone s Sleeping On?**
- Source: AD HOC NEWS | 20260104T100937 | Neutral | Relevance: 73%
- Pilgrim's Pride Corp (PPC) is presented as a "sleeper stock" that, despite its low viral status, offers solid fundamentals and consistent cash flow in the food sector. The article examines PPC's price performance, earnings power as a major chicken producer, and its risk profile, while comparing it to competitor Tyson Foods. It concludes that PPC is a good option for conservative, long-term investors seeking stable exposure to consumer staples, rather than those chasing high-volatility, viral plays.

**3. Hormel Foods Reinvents the Center of the Plate: How a Legacy Brand Is Turning Pantry Staples into a**
- Source: AD HOC NEWS | 20260105T222700 | Neutral | Relevance: 72%
- Hormel Foods is transforming from a traditional canned-meat company into a diverse protein and snacking platform, focusing on convenience, premiumization, and healthier options. The company is strategically diversifying its brand portfolio, which includes Spam, Skippy, Planters, and Applegate, to cater to varying consumer needs from value-driven to health-conscious. This reinvention aims to solidify its competitive edge in a crowded market by offering a comprehensive protein ecosystem to retailers and consumers.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-12 | Piper Sandler | $61 | $58 | +5% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-12 | Piper Sandler | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 8 ($0.00M) |
| Sells | 15 ($5.82M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 12.9% (-0.1%)
- Blackrock Inc.: 9.2% (-1.7%)
- State Street Corpora: 5.0% (+0.6%)
- Pzena Investment Man: 4.9% (+0.9%)
- Davis Selected Advis: 3.5% (+11.2%)

### Key Risks

1. Insider selling cluster: $5.8M in recent transactions.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.33 indicates undervaluation relative to growth. Analyst sentiment positive (1 raises, avg +5%). Insider selling cluster ($5.8M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $20.2B |
| Beta | 0.47 |
| 52W Range | $50.56 - $64.36 |
| Short Interest | 3.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.33 |
| Forward P/E | 13.2 |
| Current P/E | 14.8 |
| YoY Growth | 12.6% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from -0.7% to -1.9% (-1.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.9pp (needs >3.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.02x) but short-term weakness (below SMA20). RSI neutral at 48. OFD pattern: -SLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -1.92% (CS: 16) | Neutral |
| RSI_14 | 47.6 | Neutral |
| MACD Histogram | -0.26 | Bearish |
| vs SMA20 | 0.982x | Below |
| vs SMA50 | 1.027x | Above |
| vs SMA200 | 1.018x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $57.13
- **Stop Loss:** $55.09 (3.6% risk)
- **Target:** $59.17 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 281
- **Position Value:** $16,053.53
- **Portfolio %:** 16.05%
- **Risk Dollars:** $575.00
- **Risk Per Trade:** 0.57%
- **Modifiers:** L1 115% | L2 50% | Combined 0.57x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite. VIX remains calm at 14.9 (8th percentile) with positive yield curve (+65bps) and healthy breadth (59.2%), though elevated put/call ratio (1.27) suggests institutional hedging despite surface calm. Focus on quality with awareness of hedging activity divergence.*

### Earnings

**Next:** 2026-02-02 (Est: $0.95)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.83 | $1.15 | +37.8% |
| 2025Q2 | $0.78 | $0.91 | +16.2% |
| 2025Q1 | $0.82 | $0.92 | +12.2% |
| 2024Q4 | $0.88 | $1.14 | +29.9% |

---
*RULE-based L3 | 2026-01-07 09:36 | MRS_10*